BioNTech SE (BNTX) EBIT Margin (QoQ) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3,249.00 |
| Sep 30, 2025 | 18,905.00 |
| Jun 30, 2025 | 211,002.00 |
| Mar 31, 2025 | -680,519.00 |
| Dec 31, 2024 | 450,219.00 |
| Sep 30, 2024 | 294,658.00 |
| Jun 30, 2024 | 256,731.00 |
| Mar 31, 2024 | -554,862.00 |
| Dec 31, 2023 | 2,741.00 |
| Sep 30, 2023 | 34,406.00 |
| Jun 30, 2023 | -38,714.00 |
| Mar 31, 2023 | -2,572.00 |
| Dec 31, 2022 | 799.00 |
| Sep 30, 2022 | -15.00 |
| Jun 30, 2022 | -543.00 |
| Mar 31, 2022 | -1,039.00 |
| Dec 31, 2021 | 735.00 |
| Sep 30, 2021 | -149.00 |
| Jun 30, 2021 | -206.00 |
| Mar 31, 2021 | 1,045.00 |
| Dec 31, 2020 | -20,545.00 |
| Sep 30, 2020 | 8,243.00 |
| Jun 30, 2020 | -2,036.00 |
| Sep 30, 2019 | -5,699.00 |
| Jun 30, 2019 | 1,804.00 |
| Mar 31, 2019 | 16,752.00 |
| Dec 31, 2018 | 8.00 |